New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents
Department of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine
Chemicals and Drugs | Geriatrics | Health Services Administration
OBJECTIVES: To estimate the prevalence of new initiation of long-acting opioids since introduction of national efforts to increase prescriber and public awareness on safe use of transdermal fentanyl patches.
SETTING: U.S. nursing homes (NHs).
PARTICIPANTS: Medicare-enrolled long-stay NH residents (N = 22,253).
MEASUREMENTS: Minimum Data Set 3.0 was linked with Medicare enrollment, hospital claims, and prescription drug transaction data (January-December 2011) and used to determine the prevalence of new initiation of a long-acting opioid prescribed to residents in NHs.
RESULTS: Of NH residents prescribed a long-acting opioid within 30 days of NH admission (n = 12,278), 9.4% (95% confidence interval = 8.9-9.9%) lacked a prescription drug claim for a short-acting opioid in the previous 60 days. The most common initial prescriptions of long-acting opioids were fentanyl patch (51.9% of opioid-naive NH residents), morphine sulfate (28.1%), and oxycodone (17.2%).
CONCLUSION: New initiation of long-acting opioids-especially fentanyl patches, which have been the subject of safety communications-persists in NHs.
analgesics, long-acting opioid, nursing home
DOI of Published Version
J Am Geriatr Soc. 2016 Sep;64(9):1772-8. doi: 10.1111/jgs.14306. Epub 2016 Aug 3. Link to article on publisher's site
Journal of the American Geriatrics Society
Pimentel CB, Gurwitz JH, Tjia J, Hume AL, Lapane KL. (2016). New Initiation of Long-Acting Opioids in Long-Stay Nursing Home Residents. University of Massachusetts Medical School Faculty Publications. https://doi.org/10.1111/jgs.14306. Retrieved from https://escholarship.umassmed.edu/faculty_pubs/1255